Published in Telemedicine Law Weekly, September 22nd, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Amgen.
Report 2: Amgen (AMGN) reported adjusted earnings per share (EPS), excluding stock option expense and certain other expenses, of $1.04 for the third quarter of 2006, an increase of 22% compared to 85 cents during the third quarter of 2005.
Adjusted net income, excluding stock option expense and certain other expenses, increased 15% to $1,224 million compared to $1,067 million in the third quarter of 2005. Stock option expense on a per share...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Telemedicine Law Weekly